Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
2011 · New England Journal of Medicine · 9,320 citations
https://doi.org/10.1056/nejmoa1009638
R
Richard C. Becker
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
669
Papers
43.6K
Citations
81
h-index
280
i10-index
Richard C. Becker is an academic researcher from Sabin Vaccine Institute. The author has contributed to research in topics: Atrial Fibrillation Management and Outcomes & Venous Thromboembolism Diagnosis and Management & Antiplatelet Therapy and Cardiovascular Diseases. The author has an h-index of 81, co-authored 569 publications.
ORCID: 0000-0002-9878-7707Papers by this author
worksTicagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
2009 · New England Journal of Medicine · 7,018 citations
https://doi.org/10.1056/nejmoa0904327
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
2020 · The Lancet · 1,124 citations
https://doi.org/10.1016/s0140-6736(20)31792-x
Consensus Document: Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting
2011 · Thrombosis and Haemostasis · 204 citations
https://doi.org/10.1160/th11-04-0262
Circulating MicroRNA Profiling in Non-ST Elevated Coronary Artery Syndrome Highlights Genomic Associations with Serial Platelet Reactivity Measurements
2020 · Scientific Reports · 21 citations
https://doi.org/10.1038/s41598-020-63263-6
Prevalence and relevance of abnormal glucose metabolism in acute coronary syndromes: insights from the PLATelet inhibition and patient Outcomes (PLATO) trial
2019 · Journal of Thrombosis and Thrombolysis · 14 citations
https://doi.org/10.1007/s11239-019-01938-2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat